New mRNA Vaccine Reduces Risk of Melanoma Recurrence by Over 40 Percent
-
The vaccine is personalized to a patient’s tumor, and results from the
Phase 3 trial are yet another example of the promise of mRNA vaccines in
treating ca...
2 hours ago

No comments:
Post a Comment